Lose Weight and Feel Great, For Good; Text-based consults and progress tracking at home; Affordable compounded medication without insurance red tape
Our read: Adults frustrated with weight loss costs or previous diets; includes parents, men and women.
Injectable semaglutide current program page: $192 displayed | Oral semaglutide current program page: $192 displayed | Injectable tirzepatide current program page: $258 displayed | Injectable semaglutide older medication page: $225 displayed | Sublingual semaglutide older medication page: $225 displayed
Not established in the pages reviewed.
Licensed partner pharmacies, including claimed 503B facilities; no individual pharmacy named. Patient may select own pharmacy.
Google Ads Transparency Center: 0 ads headline alongside four MD Exam Inc. - DO NOT USE - IN OCA cards. No current creative verified; zero headline is not proof of no advertising. | Meta Ad Library: Brand page showed ~67 active results. Visible MDExam card started 8 Sep 2026 (ID 1048682111322614); creative copy age-gated. | LinkedIn Ad Library: No results found for MDExam keyword.
- https://adstransparency.google.com/?region=US&domain=mdexam.com&preset-date=Last+30+days ↗
- https://www.facebook.com/ads/library/?active_status=active&ad_type=all&country=US&is_targeted_country=false&media_type=all&search_type=page&sort_data[mode]=total_impressions&sort_data[direction]=desc&view_all_page_id=106586828666413 ↗
- https://www.linkedin.com/ad-library/search?keyword=MDExam ↗
2022 per LinkedIn company listing; not independently verified incorporation.
Sergio Padron (founder/CEO in third-party interview; not first-party verified)
addresses: 779 SW 9th Ave, Miami, FL 33130; 4848 SW 74 Ct Suite 201, Miami, FL 33155; type: Both published as contact/location addresses; principal office not resolved; mailbox status unverified.
Title: MD Exam | Lose Weight Feel Great; Meta description: Lose the weight for good and keep it off with MD Exam's cutting edge GLP1 programs. Affordable weight loss for everyone. Semaglutide and Tirzepatide based programs available.